Unlocking the Mystery: Stem Cell Transplant Recipients Reveal the Astonishing Journey of Donated Cells
A recent study published in Science Translational Medicine underscores the remarkable regenerative abilities of bone marrow, as observed in some of the longest-surviving recipients of hematopoietic stem cell transplants. The research, which examined 16 donor-recipient pairs over an impressive median duration of 33.6 years post-transplant, revealed that the mutation rate in donated stem cells remained surprisingly low and consistent with that of the donors, even up to 46 years after the procedure. This finding assuages concerns about the potential for clonal hematopoiesis, a condition where accumulating mutations in stem cells could lead to cancer or chronic diseases over time.
The study involved comprehensive blood sample analysis using duplex whole genome sequencing, specifically targeting genes often mutated in myeloid cancers. Results showed that while all donors exhibited clonal hematopoiesis variants early on, the mutations’ average yearly rate was minimal—2% in donors versus 2.6% in recipients. This indicates a lack of significant clonal expansion decades after engraftment, affirming the long-term stability and regenerative capacity of stem cells from bone marrow transplants.
These insights pave the way for further exploration into influencing factors such as donor age and the presence of preexisting clonal hematopoiesis, potentially impacting the long-term outcomes for transplant recipients. The study highlights the sophistication of current genomic sequencing techniques and emphasizes the crucial role of bone marrow in sustaining human health post-transplant.
Original Story https://www.thehindu.com/sci-tech/stem-cell-transplant-recipients-demystify-the-fate-of-donated-stem-cells/article68796422.ece
Category :
Tags:
Publish Date: 2024-10-27 06:00:00
